Balance Sheet
Cash Flow Statement
Beginning Cash BalanceBeginning Cash BalanceCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Change in Cash (2023 - 2025)

Mangoceuticals' Change in Cash history spans 3 years, with the latest figure at $1.0 million for Q4 2025.

  • On a quarterly basis, Change in Cash rose 14311.36% to $1.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.4 million, a 311.87% increase, with the full-year FY2025 number at $1.4 million, up 311.87% from a year prior.
  • Change in Cash hit $1.0 million in Q4 2025 for Mangoceuticals, up from $380307.0 in the prior quarter.
  • Over the last five years, Change in Cash for MGRX hit a ceiling of $3.2 million in Q1 2023 and a floor of -$1.7 million in Q3 2023.
  • Historically, Change in Cash has averaged $67186.5 across 3 years, with a median of $1571.5 in 2024.
  • Biggest five-year swings in Change in Cash: tumbled 122.7% in 2024 and later surged 14311.36% in 2025.
  • Tracing MGRX's Change in Cash over 3 years: stood at -$497741.0 in 2023, then surged by 98.58% to -$7077.0 in 2024, then surged by 14311.36% to $1.0 million in 2025.
  • Business Quant data shows Change in Cash for MGRX at $1.0 million in Q4 2025, $380307.0 in Q3 2025, and $24335.0 in Q2 2025.